genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
X-linked genetic diseases
Genome Editing
Platform Processes May Reduce AAV Gene Therapy Costs
Drug Discovery
FDA Approves Oral Nonsteroidal Treatment, Duvyzat, to Treat DMD
A-Lists
Top 10 Biopharma Takeover Targets of 2024
Genome Editing
ASHG President Brendan Lee Celebrates 75 Years of Research in Genetics and Genomics
Genome Editing
Remembering Terry Horgan
Genome Editing
Dual CRISPR RNA Method May Help Treat Duchenne Muscular Dystrophy
Drug Discovery
Door Busters: Entrada Therapeutics Is Engaging Inaccessible Intracellular Targets
Drug Discovery
Molecule May Help Overcome Symptoms of Duchenne Muscular Dystrophy
Close to the Edge
Search and Replace: Andrew Anzalone Details How Genome Editing Went Prime Time on “Close to the Edge”
GEN Edge
Rising Star: Vega Targets Rare Blood Disorders with Antibodies
1
2
3
...
18
Page 1 of 18
Recently Featured
Cytiva Introduces Its Xcellerex Magnetic Mixer at Interphex
Targets for Novel Cancer Immunotherapies Identified by Antibiotics
Universal Vaccine Strategy Boosts Body’s RNAi Response to Viruses
SPARDA: A Programmable Nucleic Acid Targeting Technology Like CRISPR
Scroll Up